PATH Cervical pre-cancer planning tool factsheet

18.06.2020

This tool developed by PATH in partnership with the Bill and Melinda Gates Foundation, is publicly available to country decision-makers who want to weigh the trade-offs of patient convenience and access, test performance, and efficient utilization of equipment, skilled personnel, and financial resources for cervical cancer. Results generated by the tool can be used to inform national screening and treatment strategies and decisions about program planning, technology selection, device procurement, and equipment deployment. Baseline data sets and dashboards for El Salvador, Ethiopia, Ghana, Guatemala, Honduras, Kenya, Malawi, Myanmar, Nicaragua, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe are already available in the tool. Other countries can use their own data to use the model by inputing their own local data.